Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.
Biogen receives a big price target increase from Biogen, EasyJet gets an upgrade from Goldman Sachs, which now believes it's time to purchase it. Meanwhile, J Sainsbury is downgraded by Jefferies.
Amgen : Oppenheimer changes PT to $277 from $272, keeps Outperform rating
Biogen: Piper Sandler raises price target to $384 From $260, maintains Neutral rating
DS Smith: Jefferies remains Buy with a price target raised from GBP 470 to GBP 480.
EasyJet: Goldman Sachs upgraded from neutral to buy with a target of GBP 1,150.
Halfords: RBC starts tracking at Outperform targeting GBp 450.